Evaluate NYX-458 in Subjects With MCI-PD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
To evaluate the safety and tolerability of NYX‐458 in mild cognitive impairments associated with Parkinson's disease and explore the potential benefit in cognition.
Epistemonikos ID: 3e7dc3c834acb24ca3c60f8e87e40662833e67ba
First added on: May 06, 2024